There are many articles in the medical and surgical literature investigating the diagnosis, pathophysiology, and treatment of endotoxin shock. However, the information concerning catecholamine release after endotoxin is not well clarified. The present study was undertaken to describe precisely the dynamics of catecholamine release after endotoxin and, in addition, to ascertain the effect of pharmacologic doses of synthetic corticosteroids on the catecholamine response to endotoxin .
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MATERIALS AND METHODS
Ten adult mongrel dogs, weighing between 15 and 25 kg, were studied under intravenous pentobarbital anesthesia, 30 mg/kg. A cuffed endotrachael tube was inserted and ventilation accomplished with a Harvard volume respirator using 98% oxygen and 2% CO, at a tidal volume of 20 cc/kg. Intravenous Ringer's lactate was administered at 100 cc/hr to all animals and the arterial pH was maintained in a physiologic range with intravenous sodium bicarbonate. Heparin was administered intravenously, 1 mg/kg, prior to cannulations and the same dose repeated hourly. Left adrenal vein to left femoral vein shunts were placed. A polyethylene catheter with a thermal dilution thermister attached was placed in the aortic arch via the carotid [l] were determined. Ten cubic centimeters of adrenal venous effluent were withdrawn at each sampling and adrenal catecholamine secretion rates calculated as a function of adrenal venousarterial catecholamine differences related to adrenal flow rate. After these baseline determinations, animals were divided into two groups of five dogs each. Group I animals received 0.5 mg/kg of E. coli endotoxin (LD,,)' injected intravenously in 10 cc normal saline over 5 min. All studies were repeated at 15,30,60, 120, and 180 min after endotoxin. After the 180-min observations, the animals were bled to a mean blood pressure of 50, stabilized for 10 min, and all studies repeated.
After initial baseline studies, Group II animals, received intravenous methyl prednisolone sodium succinate (30 mg/kg) over 5 min. They were observed for 30 min and a second set of baseline determinations obtained. At this point, as in the Group I ani- mals, E. co/i endotoxin 0.5 mg/kg (LD,,) 'was injected over 5 min intravenously. All studies were then repeated exactly as in Group I. Animals in both groups were sacrificed at the conclusion of the experimental period.
EXPERIMENTAL RESULTS
The Group I animals demonstrated increased adrenal secretion of norepinephrine at 15 min (P < 0.05),2 60 min (P < 0.05), 120 min (P < 0.02), 180 min (P < O.Ol), and after hemorrhage (P < 0.01) when compared to their baseline. These animals also showed increased adrenal secretion of epinephrine at 15 min (P < 0.05), 60 min (P < 0.05), and after hemorrhage (P < 0.02). Furthermore, animals in this group 2All results were analyzed using Student's t test.
experienced hypotension beginning at 60 min (P < 0.05) and this continued for the remainder of the experiment. Cardiac index fell to approximately 50% of baseline at 120 min (P < 0.05) and continued decreasing for the remainder of the experiment (Table 1) .
The Group II, steroid-pretreated dogs, demonstrated lower adrenal secretion of norepinephrine at all samplings, 15 min through 180 min (P < 0.02-P < 0.001) (Fig.  l) , and epinephrine (P < 0.05) at 30 and 60 min when compared to Group I animals (Fig. 2) . In addition, the arterial plasma epinephrine levels were lower in the Group II animals at 60 min (P < 0.01) (Fig. 3) . There was no difference in arterial plasma norepinephrine between the two groups (Fig. 4) . There was no difference with reference to cardiac index, mean blood pressure, and peripheral vascular resistance between the two groups (Table 2) .
DISCUSSION
The response of the adrenergic nervous system after endotoxin has not been entirely clarified. Furthermore, the effects of steroids in various forms of shock has often been contradictory. This paper has attempted to combine these two facets of research in defining the effects of corticosteroids on the sympathoadrenal system in endotoxin shock.
In 1959 Egdahl [3] studied adrenal venous catecholamines in dogs after an intravenous endotoxin injection. He demonstrated that the response of the adrenal medulla to endotoxin was dependent upon the dose of endotoxin and, furthermore, that intact neuronal pathways were necessary for the adrenal medulla to respond to endotoxin. In his study entitled "The participation of the adrenal gland in endotoxin shock," Hirkfelt [5] reported that, although adrenal flow dropped after endotoxin administration to cats, the minute output of catecholamines increased. Norepinephrine was the catecholamine initially elevated and epinephrine was increased toward the end of the observation period. In addition, Hiikfelt confirmed the finding of Egdahl that adrenal response after endotoxin involved a neurogenie mechanism and that the adrenal response was maximal in the terminal stages of endotoxin shock. Heiffer [4] , on the other NO. 4, APRIL 1975 hand, demonstrated in rabbits that after endotoxin there was no immediate increase in circulating norepinephrine or epinephrine suggesting that the sympathetic nervous system was in some fashion depressed by the endotoxin. Our results support the observations of Hiikfelt, since we were able to demonstrate increased adrenal secretion of both epinephrine and norepinephrine in the nonsteriod Group I animals at 15 min and 60 min and in addition, after endotoxin, norepinephrine secretion remained elevated during the remainder of the experiment. Plasma elevations of catecholamines were not significant except for P < 0.01 at 1 hr for epinephrine; therefore, ruling out the peripheral adrenergic nervous system as a source for the elevations found in adrenal venous effluent. Futhermore, our data do not corroborate those of Rosenberg and Lillehei [7] who speculated that endotoxin may have the ability to "temporarily deplete" peripheral stores of norepinephrine in animals subjected to endotoxin shock. The nonsteroid-treated animals (Group I) were able to raise their plasma catecholamines in a nearly stepwise fashion over the 3-hr observation period and responded with generous outpourings, albeit not significant, of epinephrine and norepinephrine in response to hemorrhage. After the pharmacologic dose of steroid plus endotoxin, the adrenal gland reacted by lowering its secretion of both norepinephrine and epinephrine. Adrenal secretion of norepinephrine in response to endotoxin appeared affected to a greater degree by steroids since its adrenal secretion was lower during the entire 3-hr observation period. Adrenal epinephrine release was also diminished. The peripheral adrenergic nervous system may be less affected by the corticosteroids since the plasma norepinephrine was no different between the two groups of dogs although epinephrine showed a trend to lower output. It is noteworthy that the adrenal gland and the peripheral adrenergic nervous system were able to react to hemorrhage in a similar fashion in both groups, indicating that the medulla and sympathetic nervous system were not totally blocked by the massive steroid administration.
A great deal has been written about the use of corticosteriods in endotoxin shock and their myriad salutatory effects ranging from an inotropic effect on the heart, to stabilizing cellular membranes and acting as vasodilators [6] . This is, however, very little direct evidence of steroid effect(s) on the adrenergic nervous system. Sambhi and Weil [8] , in analyzing the pharmacodynamic effects of glucocorticoids, showed that large doses of glucocorticoids produced a decrease in total peripheral resistance in normal patients and patients in shock. Although catecholamines were not measured in their study, they felt that this action of glucocorticoids could be a direct effect on peripheral vessels or a primary myocardial effect with secondary peripheral effects of vasodilatation. Dietzman, in an experimental and clinical report on the treatment of low cardiac output syndrome [2] showed a decrease in total peripheral resistance in dogs after 30 mg/kg of methyl prednisolone along with elevated plasma catecholamines which apparently remained unaffected by the pharmacological dose of steroids. The present study demonstrated no significant change in total peripheral resistance or cardiac index between the steroid and nonsteroid shock dogs while demonstrating as did Dietzman, elevated peripheral plasma catecholamines in shock.
In this study large doses of synthetic glucocorticoid actually blunted adrenal catecholamine output in shock when increased catecholamine secretion was expected. Indeed, the unanswered question remains why catecholamine secretion is diminished by pharmacologic doses of synthetic corticosteroids, Coupland [9] in 1953 was the first to allude to an effect of the adrenal cortex's glucocorticoids on the adrenal medulla. In 1966 Wurtman and Axelrod [lo] defined this effect of glucocorticoids on phenylethanolamine N-methyl transferase, the enzyme that methylates norepinephrine; in the presence of glucocorticoids, epinephrine is synthesized in the chromaffin cell (Fig 5) . Furthermore, although others have demonstrated decreased peripheral resistance after massive steroids een with high levels of circulating catecholamines, we showed decreased adrenal catecholamines and yet were unable to demonstrate a lowered peripheral resistance. Had we done so, we might have been able to account for the purported vasodilatory effect of steroids. Nevertheiess, pretreatment with pharmacologic doses of synthetic corticosteriods exerts a specific effect on the adrenal medulla in endotoxin shock that profoundly limits adrenal catecholamine release. SUMMARY Two groups of dogs were subjected to an LD,, of E. coli endotoxin. Group II animals were pretreated with 30 mg/kg of methyl prednisolone sodium succinate before the intravenous endotoxin. All animals had hypotension and diminished cardiac index after endotoxin administration.
The nonsteroid dogs, Group I, demonstrated increased adrenal secretion of norepinephrine and epinephrine. Arterial plasma catecholamines were comparable. Group II steroid-treated animals demonstrated lower adrenal secretion of norepinephrine and epinephrine when compared to Group I, nonsteroid animals. These results demonstrate that pretreatment with pharmacologic doses of synthetic corticosteroids exerts a specific effect on the adrenal medulla in endotoxin shock that profoundly limits adrenal catecholamine release. 
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